Advertisement

Erratum for Kim S, et al. “Comparison of Early Strut Coverage Between Zotarolimus- and Everolimus-Eluting Stents Using Optical Coherence Tomography.” Am J Cardiol 2013;111:1–5

        This paper has an error in Figure 2 on page 4. The corrected Figure 2 can be found below:
        The authors apologize for this error.
        Figure thumbnail gr1
        Figure 2Representative postintervention and 3-month follow-up OCT images. At 3 months, considerable uncovered struts and completely covered struts were observed with ZES-R and EES.

        Linked Article

        • Comparison of Early Strut Coverage Between Zotarolimus- and Everolimus-Eluting Stents Using Optical Coherence Tomography
          American Journal of CardiologyVol. 111Issue 1
          • Preview
            There have been no optical coherence tomographic (OCT) data directly comparing the pattern of strut coverage between the 2 second-generation drug-eluting stents in the early period. The aim of this prospective study was to evaluate early strut coverage using optical coherence tomography 3 months after Resolute zotarolimus-eluting stent (ZES-R) or everolimus-eluting stent (EES) implantation in de novo coronary artery lesions. A total of 40 patients who were suitable for the OCT procedure and consented to the study protocol were randomized 1:1 to receive either ZES-R or EES.
          • Full-Text
          • PDF